西蒙顾和：2024药品销售预测的狂野西部：期与现实的交汇点望白皮书（英文版）

The pharmaceutical industry faces major challenges, as patent exclusivity for around 200 drugs will expire by 2030. The magnitude of these losses of exclusivity can affect up to 79 percent of a firm’s revenue, depending on the portfolio composition of the company in question. To sustain growth amidst declining R&D productivity, leading pharmaceutical companies are increasingly turning to inorganic growth strategies, such as licensing agreements, to replenish their pipelines. For exa